Oro Lab in the News

Tumor Evolution During Drug Resistance

New Treatment Identified for Drug Resistant Basal Cell Carcinomas

February 5, 2018

2nd Annual Center for Definitive and Curative Medicine Symposium

February 27, 2018

"Innovations in the Pipeline to Curative Medicines"

Tony named Co-Director of the Stanford Child Health Research Institute

September 1, 2017

Oro lab and EB iPS Consortium awarded $5M California Institute of Regenerative Medicine Grant for Innovative Skin Stem Cell Therapy

December 7, 2017

1st Annual Center for Definitive and Curative Medicine Symposium 

February 3, 2017

"Curing the Incurable through Definitive Medicine"

Inside Stanford Medicine

"Stanford announces new Center for Definitive and Curative Medicine"

July 24, 2017

 

First Stanford Child X Conference April 2, 2015

Definitive Stem Cell & Gene Therapy for Child Health

Tony gives talk on the potential for autologous, genetically-corrected, induced pluripotent cell-derived tissue stem cells for genetic diseases like Epidermolysis bullosa

Inside Stanford Medicine

"Stanford’s lab for cell, gene medicine opens in Palo Alto"

September 6, 2016

 

Inside Stanford Medicine

"Skin tumors develop specific mutations to resist drug, researchers say"

March 9, 2015

 


Vismodegib Resistance in Basal Cell Carcinoma: Not a Smooth Fit

March 9, 2015


Therapeutic Reprogramming for the Treatment of Epidermolysis Bullosa

Inside Stanford Medicine

"Blistering skin disease may be treatable with 'therapeutic reprogramming,' researchers say"

Nov 26, 2014

 


Medical News Today

"'Therapeutic reprogramming' may lead to treatment for epidermolysis bullosa, a blistering skin disease"

Dec 1, 2014

 


Identification of the Atypical Protein Kinase C in Tumor Resistance

Inside Stanford Medicine

"Discovery opens door to multipronged attack against common skin cancer, study shows"

Feb 27, 2013

 


San Francisco Business Times

"Catching the Hedgehog: Stanford researchers uncover new way to block cancers"

Feb 27, 2013

 


Demonstration of the Efficacy of Smoothened Inhibitors for Advanced Basal Cell Carcinomas

video platform video management video solutionsvideo player " data-ui-conf-id="23332312" data-player-skin="23332312" style=" width:528px; height:297px;" itemprop="video" itemscope itemtype="http://schema.org/VideoObject"> video platform video management video solutionsvideo player ">

Stanford Cancer Treatment Called Medical Breakthrough

Inside Stanford Medicine

"Behind cancer drug, a 30-year history of scientific breakthroughs"

Jan 14, 2013